Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07089758 · ClinicalTrials.gov registry record · NA
A Study for Cerebral Open Flow Microperfusion
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT07089758: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT07089758 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07089758, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and feasibility of intra-operative microperfusion during a planned neurosurgical resection of diseased brain parenchyma, including either an epileptic focus requiring temporal lobectomy or a glioma. Devices used for microperfusion are Joanneum Research cerebral open flow microperfusion (OFM) catheters, push and pull tubing, and MPP102-II pump.
Interventions
- DEVICE Cerebral open flow microperfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2026-10 |
| Est. Completion | 2028-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07089758
The ClinicalTrials.gov registry entry for NCT07089758 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cerebral open flow microperfusion is the first listed.
NCT07089758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07089758 about?
NCT07089758 is a clinical study titled "A Study for Cerebral Open Flow Microperfusion". The purpose of this study is to evaluate the safety and feasibility of intra-operative microperfusion during a planned neurosurgical resection of diseased brain parenchyma, including either an epileptic focus requiring temporal lobectomy or a glioma. Devices used for microperfusion are Joanneum Rese...
What is the current status of trial NCT07089758?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2026-10. Estimated completion is 2028-10.
What interventions are being tested in trial NCT07089758?
The interventions under investigation include: Cerebral open flow microperfusion (DEVICE).
Who is sponsoring clinical trial NCT07089758?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.